Influence of cardiovascular health behaviors and factors on the incidence of hypertension in young and middle-aged population
Journal Title: Biomedical Transformation - Year 2024, Vol 5, Issue 4
Abstract
Objective Aims to investigate the effects of these ideal cardiovascular health behaviors and factors on the incidence of hypertension in young and middle-aged populations. Methods A cohort of 5 372 employed individuals who underwent annual health examinations at The Third Xiangya Hospital of Central South University between 2015 and 2016 was selected for the study. The incidence of hypertension was monitored, and a multivariate Cox proportional hazards regression model was applied. After adjusting for relevant factors, the risks of hypertension and cumulative effects were compared among groups with different ideal cardiovascular health behaviors and factors. Results A total of 4 883 subjects were included in the analysis, with a mean age of (37.80±9.92) years. The average follow-up period was 5.33 years, during which 1 048 new cases of hypertension were identified, resulting in a cumulative incidence rate of 21.46%. After adjusting for relevant risk factors, the risk of developing hypertension was reduced by 21% (HR=0.79, 95% CI 0.69-0.92) for non-smokers, 34% (HR=0.66, 95% CI 0.58-0.75) for those with ideal body weight, 33% (HR= 0.67, 95% CI 0.58-0.77) for regular exercisers, 80% (HR=0.20, 95% CI 0.17-0.25) for those with ideal blood pressure, and 12% (HR=0.88, 95%CI 0.77-0.99) for those with ideal cholesterol levels compared to smokers, those with nonideal body weight, non-regular exercisers, those with non-ideal blood pressure, and those with non-ideal cholesterol levels. The proportions of study subjects exhibiting 0-2, 3, 4, 5, and 6-7 ideal cardiovascular health behaviors and factors were 14.64%, 18.62%, 25.76%, 28.40%, and 12.57%, respectively, with corresponding cumulative incidence rates of hypertension at 50.35%, 32.67%, 20.83%, 6.99%, and 5.21%. Compared to individuals with 0-2 ideal cardiovascular health behaviors and factors, the risks of developing new hypertension were reduced by 33% (HR=0.67, 95% CI 0.58-0.79), 57% (HR=0.43, 95% CI 0.36-0.51), 82% (HR=0.18, 95% CI 0.14-0.23), and 85% (HR=0.15, 95% CI 0.10-0.21) for those with 3, 4, 5, and 6-7 ideal behaviors and factors, respectively. Conclusion Ideal cardiovascular health behaviors and other factors were identified as protective against the occurrence of hypertension.
Authors and Affiliations
Yan Lei, Li Ying, Wang Jiangang, Yang Pingting
Keywords
Related Articles
- EP ID EP765869
- DOI 10.12287/j.issn.2096-8965.20240413
- Views 12
- Downloads 0
The myasthenia gravis crisis with titration therapy guided by blood gas monitoring: a case report
Myasthenia gravis (MG) is an autoimmune disease characterized by postsynaptic membrane dysfunction at the neuromuscular junction. It is characterized by muscle fatigue and weakness, and its main antigen target is acetylc...
Clinical efficacy observation of yinqiao qingre tablet
Objective To evaluate the efficacy and safety of yinqiao qingre tablet in treating common cold with wind-heat type.Methods The randomized, double-blind, placebo, parallel control research were applied to this study. The...
Inhibitory effects of limonin on the proliferation of non-small cell lung cancer cells via targeting S-phase kinase-associated protein 2
Objective Aims to investigate the inhibitory effects of limonin on the proliferation of non-small cell lung cancer (NSCLC) cells and its molecular mechanisms. Methods To investigate the inhibitory effects of limonin on N...
Application and progress of tissue engineering technology in vaginal reconstruction
Vaginal defects cause immense physical and psychological stress to patients. Traditional vaginal reconstruction methods can partially restore physiological function but are often associated with long treatment periods an...
Research progress in structural modification of Camptothecins
Camptothecin and its derivatives are alkaloids with broad-spectrum anti-tumor activities and have significant inhibitory effect on malignant tumors. Its derivatives such as irinotecan and topotecan have been on market ov...